Iradimed (IRMD) Operating Expenses (2013 - 2026)

Iradimed (IRMD) has 14 years of Operating Expenses data on file, last reported at $9.6 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 1.76% year-over-year to $9.6 million in Q1 2026; TTM through Mar 2026 was $38.3 million, a 9.06% increase from a year earlier, with the FY2025 full-year figure at $38.2 million, up 11.03% from the prior year.
• Operating Expenses for Q1 2026 stood at $9.6 million, down from $9.9 million in the prior quarter.
• Over the last five years, Operating Expenses for IRMD reached as high as $9.9 million in Q4 2025 and fell as low as $6.0 million in Q2 2022.
• Historically, Operating Expenses has averaged $8.1 million across 5 years, with a median of $8.4 million in 2024.
• Across the five-year window, Operating Expenses climbed 22.36% in 2023 and climbed 1.76% in 2026, its largest moves.
• Year by year, Operating Expenses stood at $7.0 million in 2022, then rose by 18.47% to $8.3 million in 2023, then advanced by 8.57% to $9.0 million in 2024, then climbed by 10.91% to $9.9 million in 2025, then slipped by 3.63% to $9.6 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $9.6 million in Q1 2026, $9.9 million in Q4 2025, and $9.7 million in Q3 2025.